MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jcyt.2025.07.005

Медицинская библиотека · Cytotherapy · 2025

Very early recovery of T cells after alpha/beta T cell-depleted haploidentical HSCT predicts the outcome in children with leukemia.

Glushkova Svetlana, Shelikhova Larisa, Voronin Kirill, Dunaikina Maria, Blagov Sergey, Pershin Dmitriy, Vedmedskaya Viktoria, Fadeeva Maria, Arakelyan Susanna, Muzalevskii Yakov, Kazachenok Alexei, Skvortsova Yuliya, Balashov Dmitry, Maschan Alexei, Maschan Michael

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Functional immune reconstitution (IR) is a key factor in determining the success of hematopoietic stem cell transplantation (HSCT). IR depends on a number of factors and is typically delayed by ex vivo T cell depletion of the graft. αβ T cell depletion (αβ TCD) platform was reported to be associated with improved IR.

OBJECTIVE

In this retrospective study, we've focused on a homogeneous cohort of 262 children with acute leukemia first transplanted in complete remission, and investigate whether very early recovery of NK and T cells, as well as αβ and γδ T subsets, is associated with clinical outcomes.

STUDY

DESIGN

The grafts were obtained from apheresis products and processed by αβ TCD method. IR of lymphocyte subpopulations was measured in peripheral blood (PB) on day +30 after HSCT by flow cytometry.

RESULTS

The study suggests that in the early post-HSCT period, higher absolute number of T cells, despite being far below the normal range and having a rather limited T cell receptors repertoire, is associated with radically improved non-relapse mortality (NRM). Multivariate analysis confirmed the independent effect of T-cell IR on NRM. Our results show that each 10-fold increase in T cell PB count is associated with a 2.1-fold reduction in NRM (cause-specific Hazard Ratio (csHR) 0.47), independent from other important factors such as aGVHD or serotherapy use.

CONCLUSION

Based on these results we suggest that T cells recovery on day +30 after HSCT can be used in predicting NRM risk in the setting of αβ TCD HSCT. Early intervention for IR improvement can be planned.

Для цитирования: Glushkova Svetlana, Shelikhova Larisa, Voronin Kirill, Dunaikina Maria, Blagov Sergey, Pershin Dmitriy, Vedmedskaya Viktoria, Fadeeva Maria, Arakelyan Susanna, Muzalevskii Yakov, Kazachenok Alexei, Skvortsova Yuliya, Balashov Dmitry, Maschan Alexei, Maschan Michael. Very early recovery of T cells after alpha/beta T cell-depleted haploidentical HSCT predicts the outcome in children with leukemia.. Cytotherapy. 2025. DOI: 10.1016/j.jcyt.2025.07.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.